Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Jazz Pharma Plc
(NQ:
JAZZ
)
114.20
-0.04 (-0.04%)
Streaming Delayed Price
Updated: 12:22 PM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Jazz Pharma Plc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
3 No-Brainer Stocks to Buy With $300 Right Now
April 24, 2024
A modest amount of money can go a long way on Wall Street when it's put to work in time-tested businesses with well-defined catalysts.
Via
The Motley Fool
Breaking Down Jazz Pharmaceuticals: 15 Analysts Share Their Views
April 10, 2024
Via
Benzinga
How To Make Your Cannabis Business More Attractive For Investors In 2024: Advice On Financial Health & Innovation
March 25, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Analyst Landscape: 12 Takes On Jazz Pharmaceuticals
March 20, 2024
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Jazz Pharmaceuticals: Here's What You Need To Know
March 14, 2024
Via
Benzinga
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
March 13, 2024
With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.
Via
InvestorPlace
Demystifying Jazz Pharmaceuticals: Insights From 4 Analyst Reviews
February 29, 2024
Via
Benzinga
Evaluating Jazz Pharmaceuticals: Insights From 7 Financial Analysts
January 29, 2024
Via
Benzinga
Decoding 6 Analyst Evaluations For Jazz Pharmaceuticals
January 03, 2024
Via
Benzinga
Time Is Still The Enemy, Says Mom Who Moved Mountains For Her Epileptic Daughter & Still Advocates For Millions Of CBD Users
March 12, 2024
Via
Benzinga
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
February 26, 2024
Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off.
Via
InvestorPlace
4 Exhilarating Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
February 24, 2024
The Nasdaq Composite is the only major stock index that hasn't put the 2022 bear market in the rearview mirror. For patient investors, it means bargains still abound.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
3 Cannabis Stocks That Could Be Multibaggers in the Making: February Edition
February 20, 2024
Don’t miss out, as the following cannabis stocks are severely undervalued and are set to increase sales and make huge profits in 2024.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
The Queen Of Marijuana Investing Used Psychology To Launch Her Successful Cannabis Investment Fund
February 14, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Analyst Ratings for Jazz Pharmaceuticals
November 29, 2023
Via
Benzinga
3 Biotech Stocks to Buy on the Dip: February 2024
February 07, 2024
Here are three biotech stocks to buy that are trading at prices that may not account for potential breakthrough opportunities
Via
InvestorPlace
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
February 06, 2024
These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry.
Via
InvestorPlace
4 Eye-Catching Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
February 03, 2024
The growth-fueled Nasdaq Composite remains nearly 6% below its all-time high, which means amazing deals can still be found.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for January 2024
January 31, 2024
Biotech stocks are warming up in January and look to continue upward in 2024 as the economy improves. Here are three to check out.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Japanese University Will Research Marijuana's Medical Uses In First-Of-Its-Kind Collaboration With Australian Company
January 31, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
2 Incredible Growth Stocks That Are Screaming Buys for 2024
January 22, 2024
These healthcare businesses are compelling buys for very different reasons.
Via
The Motley Fool
4 Remarkable Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
January 13, 2024
The growth-fueled Nasdaq Composite remains 7% below its all-time high, which means bargains can still be found.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
US Stocks Set To Open Weaker As Traders Eye Key Main Street Events: Analyst Sees Buying Opportunity On 'Stunning' Earnings Expectations
January 03, 2024
Several market-moving catalysts, including the release of the Fed minutes, a Federal Reserve speech, and JOLTS data, could influence the day's market movement.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
7 Growth Stocks Poised to Thrive in a Post-Fed Pivot World
December 28, 2023
If the Federal Reserve loosens the monetary spigot, these companies could represent the growth stocks to buy now.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
Jazz Pharmaceuticals' Post-Traumatic Stress Disorder Drug Disappoints In Mid-Stage Study
December 22, 2023
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced top-line results from the Phase 2 trial of JZP150, an investigational small molecule selective fatty acid amide hydrolase (FAAH) inhibitor, on efficacy...
Via
Benzinga
3 No-Brainer Stocks to Buy With $500 Right Now
December 20, 2023
You don't need a mountain of cash to build wealth on Wall Street.
Via
The Motley Fool
Japan Approves Marijuana-Derived Medicines, Adopt 7-Year Prison Sentences For Recreational Use
December 06, 2023
Japan’s Parliament passed a bill Wednesday legalizing medical products derived from cannabis.
Via
Benzinga
Australian MPs Admit They Tried Cannabis, Signaling Policy Reform & Epidiolex For Seizures Approved In Canada
November 30, 2023
Around 8% of Australians are using medical marijuana either occasionally or regularly, according to a recent survey of 1,000 participants conducted by consumer insights company Antenna, reported...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
3 Top-Rated Biotech Stocks That Analysts Are Loving Now
November 28, 2023
Investing in biotech stocks can be tricky, but analysts have bullish outlooks on these three, promising companies.
Via
InvestorPlace
Pot Stocks: Values Or Traps?
November 22, 2023
Pot stocks were the hottest thing around five years ago but after catching a bid during the pandemic, the stocks have now plunged to multi-year lows.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.